Skip to main content

NHGRI Doles Out $32M in New Sequencing Grants; Adds to Last Year s $38M Funding

NEW YORK, Aug. 8 (GenomeWeb News) - The National Human Genome Research Institute has awarded grants totaling more than $32 million to advance the development of new technologies designed to cut the cost of DNA sequencing and expand the use of genomics in biomedical research and healthcare.

 

According to the NHGRI, the cost of DNA sequencing has fallen more than 50-fold over the past 10 years. However, it still costs about $10 million to sequence 3 billion base pairs. These grants add to the $38 million the NGHRI issued last October to help pay for the development on newer sequencing technologies.

 

The NHGRI said it would like to see the cost of sequencing a mammalian-sized genome cut to $100,000 in the near-term. Among the researchers who received grants to achieve this goal are Agencourt Personal Genomics' Gina Costa, who received a commitment of $1.2 million over two years; the State University of New York's Vera Gorfinkle, who received a 2-year grant worth $1.5 million; and Network Biosystems' Greg Kellogg, who received a $4.5 million, 3-year grant.

 

The NHGRI also awarded numerous grants to researchers looking to cut the cost of sequencing a mammalian-sized genome to $1,000 or less. Among these grant recipients are Duke University's Richard Fair, who was awarded a $510,000, 2-year grant; Reza Ghadiri from the Scripps Research Institute and Oxford University's Hagan Bayley, who received a 5-year grant worth $4.2 million; and Stephen Turner of Nanofluidics, who received a 3-year grant worth $6.6 million.

 

Additional details about the grants and their recipients can be found here.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.